» Articles » PMID: 30119893

Anti-survivin Single-domain Antibodies Derived from an Artificial Library Including Three Synthetic Random Regions by In vitro Selection Using CDNA Display

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2018 Aug 19
PMID 30119893
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Single-domain antibodies (variable domain of the heavy chain of a heavy chain antibody; VHH) are promising reagents for therapeutics and diagnostics because of their stability, cost-effective production and material workability as a small antibody. Currently, general acquisition of a VHH using immunization of camelids is inconvenient from the standpoint of animal protection, cost and the process is time-consuming. Thus, a straightforward and efficient method for screening VHHs against a target molecule is required. In this study, we examined whether in vitro selection of a VHH against a target protein could be performed by a cDNA display method with an artificial VHH library that had the three complementarity-determining regions (CDRs) randomized by chemical synthesis. The results revealed that a particular VHH against survivin, which is a member of the inhibitor of apoptosis family, was selected with affinity in the range of 10 to 10 M. The in vitro selection of a VHH using cDNA display with an artificial synthesized library without animal immunization was shown to be effective for rapid and inexpensive screening of VHHs against a target protein.

Citing Articles

Single-chain antibody gene therapy strategy based on high-throughput screening triggers sustained antiviral activity in the body.

Zhao L, Wei X, Xu K, Zhao Z, Chen G, Wang H J Virol. 2024; 99(1):e0149724.

PMID: 39714166 PMC: 11784017. DOI: 10.1128/jvi.01497-24.


Cell-Free Gene Expression: Methods and Applications.

Hunt A, Rasor B, Seki K, Ekas H, Warfel K, Karim A Chem Rev. 2024; 125(1):91-149.

PMID: 39700225 PMC: 11719329. DOI: 10.1021/acs.chemrev.4c00116.


Screening and construction of nanobodies against human CD93 using phage libraries and study of their antiangiogenic effects.

Miao H, Wu Y, Ouyang H, Zhang P, Zheng W, Ma X Front Bioeng Biotechnol. 2024; 12:1372245.

PMID: 38751868 PMC: 11094214. DOI: 10.3389/fbioe.2024.1372245.


Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics.

Zhang Q, Zhang N, Xiao H, Wang C, He L Cancers (Basel). 2023; 15(23).

PMID: 38067344 PMC: 10705070. DOI: 10.3390/cancers15235639.


Magnetic Nanoparticle-Based Semi-automated Panning for High-Throughput Antibody Selection.

Chng A, Konthur Z, Lim T Methods Mol Biol. 2023; 2702:291-313.

PMID: 37679626 DOI: 10.1007/978-1-0716-3381-6_15.